Event Details

Acorda Therapeutics, Inc. Provides Update on Tozadenant Development Program

November 15, 2017 Time: 08:30 AM EST

Stock Quote

ACOR (Common Stock) $ 21.05 +0.00 (+0%) Volume: 962,102 MORE December 15, 2017

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *





 
Enter the code shown above.